Medications

FDA approves first drug for rare form of rickets

(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).

Psychology & Psychiatry

Mental health 'labels' can do more harm than good, warn researchers

Diagnosing patients with medical labels to describe mental health conditions or severe mental health illnesses such as 'personality disorder' or 'schizophrenia', can have negative impacts on professionals working with them ...